John R. Boot

612 total citations
26 papers, 458 citations indexed

About

John R. Boot is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, John R. Boot has authored 26 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Cellular and Molecular Neuroscience and 7 papers in Physiology. Recurrent topics in John R. Boot's work include Neuroscience and Neuropharmacology Research (7 papers), Nicotinic Acetylcholine Receptors Study (7 papers) and Receptor Mechanisms and Signaling (6 papers). John R. Boot is often cited by papers focused on Neuroscience and Neuropharmacology Research (7 papers), Nicotinic Acetylcholine Receptors Study (7 papers) and Receptor Mechanisms and Signaling (6 papers). John R. Boot collaborates with scholars based in United Kingdom, United States and India. John R. Boot's co-authors include David J. Osborne, David J. Edwards, C. Robinson, Bethan Lang, John Newsom–Davis, Fraser J. Moss, Ashwin Pinto, Mark E. Williams, Stephen Baker and Paul F. Brust and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Brain Research and Biochemical and Biophysical Research Communications.

In The Last Decade

John R. Boot

26 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John R. Boot United Kingdom 13 214 127 99 86 79 26 458
Peter Ström Sweden 13 313 1.5× 349 2.7× 69 0.7× 47 0.5× 51 0.6× 23 772
Takeshi Matsugi Japan 14 170 0.8× 50 0.4× 64 0.6× 22 0.3× 87 1.1× 25 685
P.-A. Löschmann Germany 12 294 1.4× 287 2.3× 38 0.4× 211 2.5× 95 1.2× 19 822
Michio Terai United Kingdom 11 362 1.7× 240 1.9× 75 0.8× 24 0.3× 69 0.9× 24 613
M. S. NOBBS United Kingdom 10 312 1.5× 237 1.9× 181 1.8× 31 0.4× 40 0.5× 21 598
Claudia Keller Switzerland 17 217 1.0× 159 1.3× 32 0.3× 20 0.2× 78 1.0× 34 495
N. N. Share Canada 14 139 0.6× 115 0.9× 51 0.5× 18 0.2× 81 1.0× 33 541
Larry P. Bausher United States 11 211 1.0× 106 0.8× 141 1.4× 20 0.2× 31 0.4× 21 515
Dieter Seidelmann Denmark 6 189 0.9× 190 1.5× 100 1.0× 9 0.1× 55 0.7× 10 499
Michèle Rizzolio United States 12 181 0.8× 69 0.5× 117 1.2× 10 0.1× 104 1.3× 22 616

Countries citing papers authored by John R. Boot

Since Specialization
Citations

This map shows the geographic impact of John R. Boot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Boot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Boot more than expected).

Fields of papers citing papers by John R. Boot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Boot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Boot. The network helps show where John R. Boot may publish in the future.

Co-authorship network of co-authors of John R. Boot

This figure shows the co-authorship network connecting the top 25 collaborators of John R. Boot. A scholar is included among the top collaborators of John R. Boot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John R. Boot. John R. Boot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bueno, Ana B., Jeremy Gilmore, John R. Boot, et al.. (2007). Naphthyl piperazines with dual activity as 5-HT1D antagonists and 5-HT reuptake inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(12). 3344–3348. 6 indexed citations
2.
Baker, Stephen, John R. Boot, David Dobson, et al.. (2005). High affinity ligands for the α7 nicotinic receptor that show no cross-reactivity with the 5-HT3 receptor. Bioorganic & Medicinal Chemistry Letters. 15(21). 4727–4730. 9 indexed citations
3.
Beadle, Christopher D., John R. Boot, Nicholas P. Camp, et al.. (2005). 1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(20). 4432–4437. 32 indexed citations
4.
Torrado, Alicia, Carlos José Einicker Lamas, Javier Agejas, et al.. (2004). Novel selective and potent 5-HT reuptake inhibitors with 5-HT1D antagonist activity: chemistry and pharmacological evaluation of a series of thienopyran derivatives. Bioorganic & Medicinal Chemistry. 12(20). 5277–5295. 12 indexed citations
5.
Pullar, Ian A., et al.. (2004). The role of the 5-HT1D receptor as a presynaptic autoreceptor in the guinea pig. European Journal of Pharmacology. 493(1-3). 85–93. 34 indexed citations
6.
Boot, John R., Barry P. Clark, Jeremy Findlay, et al.. (2004). Discovery and structure–activity relationships of novel selective norepinephrine and dual serotonin/norepinephrine reuptake inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(3). 699–703. 27 indexed citations
7.
Boot, John R., Jane Cooper, Jeremy Findlay, et al.. (2004). SAR development of a selective 5-HT1D antagonist/serotonin reuptake inhibitor lead using rapid parallel synthesis. Bioorganic & Medicinal Chemistry Letters. 14(10). 2469–2472. 9 indexed citations
8.
Boot, John R., et al.. (2003). Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression. Bioorganic & Medicinal Chemistry Letters. 13(19). 3277–3280. 13 indexed citations
9.
Broad, Lisa M., Ruud Zwart, Gordon I. McPhie, et al.. (2002). PSAB-OFP, a selective α7 nicotinic receptor agonist, is also a potent agonist of the 5-HT3 receptor. European Journal of Pharmacology. 452(2). 137–144. 27 indexed citations
10.
Pullar, Ian A., John R. Boot, Stephen Carney, et al.. (2001). In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT1B/1D/2 receptor antagonist properties. European Journal of Pharmacology. 432(1). 9–17. 11 indexed citations
11.
Pinto, Ashwin, Fraser J. Moss, Bethan Lang, et al.. (1998). Differential Effect of Lambert‐Eaton Myasthenic Syndrome Immunoglobulin on Cloned Neuronal Voltage‐gated Calcium Channelsa. Annals of the New York Academy of Sciences. 841(1). 687–690. 8 indexed citations
12.
Lang, Bethan, Sally A. Waterman, Ashwin Pinto, et al.. (1998). The Role of Autoantibodies in Lambert‐Eaton Myasthenic Syndromeaa. Annals of the New York Academy of Sciences. 841(1). 596–605. 19 indexed citations
13.
Boot, John R., et al.. (1997). Differential effects of voltage dependent Ca2+ channels on low and high frequency mediated neurotransmission in guinea-pig ileum and rat vas deferens. European Journal of Pharmacology. 335(1). 31–36. 11 indexed citations
14.
Boot, John R.. (1994). Differential effects of ω-conotoxin GVIA and MVIIC on nerve stimulation induced contractions of guinea-pig ileum and rat vas deferens. European Journal of Pharmacology. 258(1-2). 155–158. 29 indexed citations
15.
Edwards, David J., et al.. (1993). Stimulated eosinophils and proteinases augment the transepithelial flux of albumin in bovine bronchial mucosa. British Journal of Pharmacology. 110(2). 840–846. 12 indexed citations
16.
Boot, John R., et al.. (1993). The pharmacology of LY290324 in the guinea-pig: an orally active, potent and selective cysteinyl leukotriene receptor antagonist. European Journal of Pharmacology. 231(1). 83–89. 3 indexed citations
17.
Boot, John R. & Ann Bond. (1992). The effect of Ca2+ channel modulators on vagally induced bronchoconstriction in the guinea-pig. European Journal of Pharmacology. 219(1). 123–128. 5 indexed citations
18.
Edwards, David J., et al.. (1991). In vitro modulation of the eosinophil‐dependent enhancement of the permeability of the bronchial mucosa. British Journal of Pharmacology. 104(2). 391–398. 27 indexed citations
19.
Meade, Christopher J., et al.. (1984). γ-Hexachlorocyclohexane stimulation of macrophage phospholipid hydrolysis and leukotriene production. Biochemical Pharmacology. 33(2). 289–293. 18 indexed citations
20.
Baker, Stephen, John R. Boot, & David J. Osborne. (1982). A comparative study of the physical properties and enzymatic reactions of slow reacting substance of anaphylaxis and some leukotriene D4 isomers. Prostaglandins. 23(4). 569–577. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Ström Breakdown of academic impact, for papers by Takeshi Matsugi Breakdown of academic impact, for papers by P.-A. Löschmann Breakdown of academic impact, for papers by Michio Terai Breakdown of academic impact, for papers by M. S. NOBBS Breakdown of academic impact, for papers by Claudia Keller Breakdown of academic impact, for papers by N. N. Share Breakdown of academic impact, for papers by Larry P. Bausher Breakdown of academic impact, for papers by Dieter Seidelmann Breakdown of academic impact, for papers by Michèle Rizzolio
Rankless by CCL
2026